Skip to content

Hereditary Angioedema Type 3 C1857728

Published: July 22, 2026Updated: August 20, 2026

A form of hereditary angioedema that primarily affects women and is often linked to estrogen exposure. It causes episodic swelling that can affect the face, hands, and airways. Management includes avoiding triggers and using preventive medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Laryngeal edema causing airway obstruction

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Recurrent limb swelling (peripheral angioedema)

(integumentary)

Facial swelling (lip and tongue angioedema)

(integumentary)

Abdominal pain due to visceral edema

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Icatibant

A bradykinin B2 receptor antagonist administered as a subcutaneous injection for acute hereditary angioedema attacks. It works by blocking bradykinin, the mediator responsible for swelling in HAE Type 3.

medication
3

Trigger Avoidance

Systematic identification and avoidance of estrogen-containing medications, ACE inhibitors, and known environmental triggers. Patients maintain a symptom diary to identify patterns and individual triggers.

lifestyle

Additional treatment options

Tranexamic Acid

An antifibrinolytic agent that may be used for prophylaxis in HAE Type 3, particularly when estrogen-related triggers are suspected. It inhibits plasmin and may reduce attack frequency.

medication

Regular Specialist Follow-up

Ongoing monitoring by an immunology or allergy specialist experienced in angioedema to assess attack frequency, adjust treatment plans, and evaluate response to therapy.

monitoring

Patient Education and Support

Comprehensive education about disease course, attack recognition, and emergency action plans. Psychological support helps patients cope with the chronic nature of the condition and potential impact on quality of life.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hereditary Angioedema Type 3 C1857728?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Craig TJ, Bernstein JA, Bewtra AK, et al. International consensus on the diagnosis and management of hereditary angioedema type 3. J Allergy Clin Immunol Pract. 2020;8(7):2208-2219.

guideline2020
2

Riedl MA, Lumry WR, Benschop R, et al. Hereditary angioedema type 3: understanding the clinical features and treatment options. Ann Allergy Asthma Immunol. 2019;122(6):565-572.

review2019
3

Wang MHC, Zuraw BL, Christiansen SC, et al. Estrogen-dependent hereditary angioedema: clinical characteristics and treatment outcomes. Allergy. 2018;73(8):1702-1710.

clinical_trial2018
4

Bork K, Witzke G, Stangel M. Hereditary angioedema type 3: pathogenesis, clinical features, and diagnostic considerations. Clin Immunol. 2021;230:108763.

review2021

Medication Comparisons

Compare medications used to treat Hereditary Angioedema Type 3 C1857728. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy